It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM (very low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE (very low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects compared with COMBINATIONS: h. RISPERIDONE + CLONAZEPAM (very low certainty).
HALOPERIDOL may leads to higher adverse effects compared with OTHER ANTIPSYCHOTICS: g. QUETIAPINE (low certainty).
HALOPERIDOL showed no clear difference in adverse effects: specific compared with COMBINATIONS: e. HALOPERIDOL + RISPERIDONE (low certainty).
The review found no eligible studies for this question.
HALOPERIDOL probably leads to lower adverse effects ‐ other ‐ Sedation compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (moderate certainty).
HALOPERIDOL showed no clear difference in adverse effects: specific ‐ seizure compared with COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE (low certainty).
HALOPERIDOL showed no clear difference in adverse effects: specific ‐ dystonia compared with OTHER ANTIPSYCHOTIC: c. DROPERIDOL (moderate certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects: specific ‐ tachycardia compared with OTHER ANTIPSYCHOTIC: i. THIOTHIXENE (very low certainty).
HALOPERIDOL may leads to higher adverse effects: specific ‐ acute dystonia compared with COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE (low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects: specific ‐ tremor by 7 days compared with OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE (very low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects ‐ at least one adverse effect compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (very low certainty).
HALOPERIDOL showed no clear difference in adverse effects: Specific ‐ EPS during 24 hours compared with OTHER ANTIPSYCHOTIC: h. RISPERIDONE (low certainty).
HALOPERIDOL probably leads to higher adverse effects: Movement disorders ‐ parkinsonism compared with PLACEBO (moderate certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects: Specific ‐ dystonia during 24 hours compared with OTHER ANTIPSYCHOTIC: e. OLANZAPINE (very low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects: Specific ‐ dystonia within 24 hours compared with PLACEBO/NIL (very low certainty).
It is very uncertain whether HALOPERIDOL changes adverse effects: Specific ‐ dystonia during 72 hours compared with OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE (very low certainty).